|
HS Code |
539864 |
| Chemicalname | Methyl 4-Iodobenzoate |
| Casnumber | 619-44-3 |
| Molecularformula | C8H7IO2 |
| Molecularweight | 262.05 g/mol |
| Appearance | White to off-white crystalline powder |
| Meltingpoint | 80-83 °C |
| Boilingpoint | 312.9 °C at 760 mmHg |
| Density | 1.73 g/cm³ |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in water; soluble in organic solvents such as ethanol and ether |
As an accredited Methyl 4-Iodobenzoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Methyl 4-Iodobenzoate, 25g, supplied in a tightly sealed amber glass bottle, labeled with hazard warnings and product details. |
| Shipping | Methyl 4-Iodobenzoate is shipped in tightly sealed containers, protected from light and moisture. It must be handled according to standard chemical safety protocols, including proper labeling and documentation. Transport complies with relevant regulations (such as DOT/IATA/IMDG), typically as a non-hazardous or limited quantity substance. Avoid heat, sparks, and strong oxidizers during shipping. |
| Storage | Methyl 4-Iodobenzoate should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from direct sunlight and moisture. Keep it away from incompatible substances such as strong oxidizing agents. Store at room temperature, protected from physical damage, and properly labeled. Follow standard laboratory chemical storage guidelines to ensure safety and stability. |
Applications of Methyl 4-Iodobenzoate in Industrial ManufacturingMethyl 4-Iodobenzoate serves as a high-purity intermediate that is widely used in specialized sectors of the chemical, pharmaceutical, and electronics industries. Below, we detail confirmed industrial application scenarios, with an emphasis on formulation, regulatory compliance, integration into processing lines, and typical downstream product types as encountered in global B2B manufacturing supply chains. 1. Pharmaceutical Intermediate for Active Pharmaceutical Ingredients (APIs)Methyl 4-Iodobenzoate plays a critical role as an acylating and arylating intermediate in the synthesis of complex APIs, including antihypertensive and anti-inflammatory drugs. In high-volume pharmaceutical manufacturing, process chemists introduce this raw material during late-stage functionalization—specifically, for incorporating iodine moieties by Suzuki or Sonogashira couplings. Achieving controlled substitution ensures pharmacologically active molecules with improved bioavailability and target selectivity. Plant-level handling follows strict cGMP protocols, with batch records ensuring traceable additive quantities throughout the multi-step synthesis pipeline. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Synthesis of Liquid Crystal Compounds for Display TechnologyManufacturers of high-performance liquid crystal display (LCD) materials select Methyl 4-Iodobenzoate for its reliable coupling efficiency in forming rigid, anisotropic benzoate cores through palladium-catalyzed reactions. Production engineers dose it during liquid crystal core assembly, tailoring physical properties such as birefringence, dielectric anisotropy, and UV stability. Strict monitoring of purity and halide content ensures downstream consistency and minimizes spectral defects in finished display films. Integration with automated synthesis lines enables scaling from pilot to mass production for optoelectronic components. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Synthesis for Functionalized HerbicidesAgrochemical manufacturers use Methyl 4-Iodobenzoate as a key building block for constructing aryloxybenzoate frameworks present in new-generation herbicides. Its consistent reactivity enables regioselective introduction of iodo-substituted aromatic rings, contributing to potent mode-of-action profiles. Production incorporates the intermediate during core skeleton assembly and subsequent etherification, with precise control over concentration to minimize off-target impurities. Formulation and scaling follow regulatory norms for agricultural chemical actives, ensuring residue and impurity levels suit end-use registration criteria. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Organic Synthesis for Specialty Dye IntermediatesManufacturers within the colorant and high-purity dye sector employ Methyl 4-Iodobenzoate in the synthesis of functional intermediates for high-performance dyes, particularly those requiring strong chromophores for technical textiles and advanced imaging. The ester’s clean reactivity supports regioselective coupling and enables production of dye intermediates with enhanced light fastness and stability. Technicians introduce the material at controlled stages of the dye backbone synthesis, calibrating input to maximize output yield without compromising color purity or spectral absorption standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Building Block for Advanced Electronic MaterialsIn specialty electronic materials manufacturing, chemical engineers utilize Methyl 4-Iodobenzoate for constructing functional aromatic units required in advanced photoresist and dielectric material synthesis. Its reliable purity and halogen content enable high-yield reactions during aryl halide coupling, which is pivotal for patternable material production. Careful additive ratio control at the functionalization stage results in uniform batch quality and minimized electronic migration risk, a necessity for semiconductor and PCB industries. End-product QC confirms compliance to both physical and electronic performance criteria. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Methyl 4-Iodobenzoate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in a chemical manufacturing plant has taught us that every compound on the shelf must earn its place. Methyl 4-Iodobenzoate often stands out, not because of any marketing effort, but because its structure and purity directly impact the outcome of advanced syntheses. Over the years, demand keeps growing—not from the lure of trend, but because chemists rely on performance shot through consistency.
This compound, known for its iodine at the para position, serves a much higher purpose than its basic label might suggest. When you hold a bottle of Methyl 4-Iodobenzoate in hand, you’re looking at the product of careful reaction controls, vacuum distillation, and meticulous purification. Chemists in pharmaceuticals, agrochemicals, and materials research know its role as a key building block for complex molecules. Our everyday work revolves around producing batches where purity means the difference between project success and failure, especially for applications laying foundations for cancer therapeutics and new catalysts.
Consistency doesn’t happen by accident. Our facility has spent years tuning reaction parameters—from moisture exclusion during the esterification of 4-iodobenzoic acid to the final drying stage. With regular calibrations and careful solvent monitoring, the factory team charts every step. Each batch of Methyl 4-Iodobenzoate delivers a precise melting point, matches the expected color, and presents a uniform crystalline texture. These cues aren’t superficial: a subtle shift might warn of unwanted byproducts or incomplete reactions.
Purity checks—routinely done by GC and NMR—aren’t just regulatory. They’re the daily language of our lab teams who know that even trace contaminants create noise in reaction profiles. Our grade regularly exceeds 98% purity, with most batches crossing the 99% mark. There’s no shortcut here; unwanted halides or esters show up in product yields downstream, and we feel the effects not just in numbers but in partners’ trust.
Years of hands-on experience tell us that buyers care most about what arrives in the drum or glass bottle—not what a catalog claims. Methyl 4-Iodobenzoate doesn’t tolerate guesswork. Its practical features are easy to spot: a white, crystalline powder, solubility favoring common organic solvents, a solid melting point around 75-79°C, and a molar mass of 262.05 g/mol. Experience with hundreds of batches allows us to spot real deviations. Slight discoloration means dehydration might be compromised; moisture content must fall below 0.5%. Repeated purity control and water titration reflect the needs of synthetic chemists who never want the uncertainty of a mixed-ester contaminant.
By running reactions in jacketed glassware with nitrogen protection and performing post-synthesis crystallization using high-purity methanol, every step supports the integrity of the final product. Each shipment completes HPLC and NMR analysis, logged with batch numbers, giving users the security we’ve been expected to deliver—and do.
Inside the medicinal chemistry sector, researchers lean on Methyl 4-Iodobenzoate for the strategic coupling reactions that underpin structure-activity relationships. One example—preparing potential kinase inhibitors—demands exact substitution at the para position. The iodine atom opens the door for Suzuki, Sonogashira, or Heck couplings without the reactivity problems seen in less stable halides.
Others use it as a launching point for custom liquid crystal materials. The ester group and aromatic ring introduce rigidity and polarity, tuning alignment properties in advanced display technologies. Our technical team frequently gets feedback from clients who notice differences in batch cleanliness based on their own thin-layer chromatography checks. Cleaner starting materials mean fewer purification cycles later, translating to fewer solvent barrels and less wasted time.
Every synthesis route forces users to weigh options: go with a cheaper brominated analog, or stick with the more reactive iodinated product. From what we've seen in various process development meetings, price differences tempt project managers, but reactivity and selectivity tip the scales. Methyl 4-Iodobenzoate, with its strong leaving group at the para position, simplifies cross-coupling reaction development compared to methyl 4-bromobenzoate or methyl 4-chlorobenzoate.
Take, for example, a Suzuki-Miyaura reaction targeting a difficult biaryl connection. The iodide enables lower catalyst loadings and greater tolerance to functional groups—all major time-savers for scale-up. Our customer development scientists tracked yields across halide series, and the iodo compound consistently offered higher conversions under milder conditions, even when the substrate was challenging. Though brominated versions tempt with lower costs, batch-to-batch reproducibility often falls short. This isn’t theory for us—it’s what our customers report back after pilot runs.
Our plant keeps pace with rising documentation standards. Pharmaceutical partners expect full traceability and analytical documentation—chromatograms, certificates, impurity profiles—because regulators in key markets ask detailed questions. To provide seamless approval processes, we maintain digital production logs, GMP-aligned SOPs, and a digital archive of every analytical test from the last ten years.
Beyond paperwork, compliance means investing in waste handling infrastructure and training operators to detect subtle process changes before they become issues. Years ago, an electrical fault in a vacuum pump led to a barely perceptible yellow tint in a single batch. Instead of releasing it, the team traced the root cause and quarantined the lot. Such decisions slow shipping in the moment, but save face and relationships for years.
Vapors from iodinated compounds carry a sharp odor and can irritate if not vented carefully. In our experience, the difference between a safe plant and a dangerous one comes down to training and vigilant air monitoring. Modern batch enclosures and effective scrubber systems prevent both worker discomfort and environmental discharge. Handling iodine reagents, byproducts, and spent solvents through a closed-loop recycling setup keeps exposure levels low and reduces regulatory headaches.
Best outcomes follow clear worker protocols: gloves, goggles, and fitted masks aren’t optional. Routine audits, unannounced by the EHS team, push us to keep all safety measures sharp. The few accidents that have happened always traced back to moments when someone tried to cut corners. Sharing those lessons in every onboarding session means new hands learn from our past and help keep the plant running clean and safe.
Shipping Methyl 4-Iodobenzoate isn’t just a task for the back office; missed details result in customer complaints, reactant losses, or worse, regulatory fines. We switched to lined, air-tight drums a few years ago after one season’s humidity caused partial hydrolysis in a shipment. Since then, our packaging team runs routine checks for seal integrity and moisture absorption before a crate ever leaves the loading dock.
Clients working in humid climates bring up shelf-life concerns. Preparing for long transit, our team now uses desiccant packs—even for smaller quantities. Over the years, we’ve learned to double-check the labeling, batch numbers, and hazard marks. Our logistics coordinator still retells a story about a box mislabeled with a similar ester—an oversight that cost both us and our client weeks of project time. By treating each shipment as irreplaceable, mistakes have dropped close to zero.
From the outside, specification sheets rarely tell the full story. Labs using Methyl 4-Iodobenzoate for peptide synthesis or fine chemical intermediates report that even tiny residuals—say, leftover acid, less than 0.5%—can disrupt coupling efficiency. Since our staff participate in process development discussions with customers, these feedback loops push us to further tighten filtration, recrystallization, and drying steps.
We’ve seen requests for ultra-high purity (99.5%+) increase year after year, pushed by precision needs in electronics or for active pharmaceutical ingredient intermediates. Several pilot scale-ups have exposed how minor impurities left undetected by standard specification checks can poison palladium catalysts and devastate yield. We respond by extending running times on our chromatographic columns, running head-to-tail fraction monitoring, and sending early samples to customers for their own validation.
Lab results only matter if they scale. We regularly consult with end users who aim to ramp synthesis from gram to kilogram quantities. At this point, questions commonly shift from “how pure” to “how repeatable.” Projects that succeed over the long haul rely on a predictable melting point curve and repeatable reaction yields, batch after batch. It takes tight process discipline, strong supplier relationships for raw 4-iodobenzoic acid, and troubleshooting skills learned over hundreds of runs to deliver what users expect.
A team of engineers oversees each run, tracking reaction exotherms, pressure swings, and distillation temperatures. If we see deviations in color or crystal structure, a cross-functional team steps in, retracing steps—a disruption that can save an entire customer program. Lessons from one batch inform the entire monthly schedule; knowledge accumulates with every cycle.
Many ask why not substitute another ester or a different halide. Over the past decade, we’ve tested performance in real-world catalysis screens—a two-step etherification, for example, that works on paper but stalls in the pilot plant when species other than methyl 4-iodobenzoate enter the mix. Iodine’s leaving group ability can’t be matched with chlorine or bromine, particularly where late-stage functionalization is required to build complex, drug-like molecules.
We’ve sampled imported alternatives produced by low-cost overseas suppliers. On paper, some batches carry similar purity marks, but practical differences turn up in solvent extracts, melting point ranges, and reactivity profiles. Some show trace metals leftover from less rigorous manufacturing, leading to fouling in subsequent coupling reactions. Our regular analytical campaigns reveal these differences, sparking conversations with clients who question why a small cost saving can lead to a major project setback.
Listening to synthetic chemists guides our continuous improvement. Their needs shape our production decisions, especially as the pharmaceutical sector shifts focus toward more complex heterocycles and fragment-based pipelines. We’ve responded by investing in more robust analytical capacity—two new NMR machines, a high-res mass spec, and greater traceability in raw material sourcing.
Our field representatives meet researchers at conferences and on site visits. They report stories from labs where a trouble-free batch of Methyl 4-Iodobenzoate clinched a tough patent filing; or the opposite—a contaminated batch set back research weeks, costing both time and credibility. Such cases motivate investment in quality and direct contact, not faceless online transactions. If a batch ever skirts the line on our internal purity threshold, it never goes out the door.
Overseeing hundreds of kilogram-scale productions, one memory stands out—a major API project faced with catalyst deactivation. Investigation traced the cause to minuscule bromide traces from an alternate benzoate. Only replacing it with a high-purity, freshly produced Methyl 4-Iodobenzoate restored full catalytic activity, enabling product release and project continuation.
Another team working in OLED precursor synthesis ran into issues with byproduct fluorides when using a competitor’s ester. Sharing NMR and HPLC traces, we showed how fastidious iodine handling during our synthesis pipeline eliminated side reactions. After switching over, they reported yield jumps and lower waste disposal costs. Over time, these stories reinforce both the trust and the technical need for high-purity, reliably-produced iodinated esters.
Complex syntheses bring unexpected problems. Having Methyl 4-Iodobenzoate in the chemistry toolbox lets researchers pursue late-stage diversification, forge new aryl-amine bonds, and optimize conditions for sensitive functional groups. The push for greener processes led our R&D staff to test it under a variety of cross-coupling catalysts—finding lower catalyst loads and reduced byproduct formation. By working closely with end-users, we help them fine-tune reaction parameters, adapting purity or particle size where necessary.
For specialty electronics or diagnostic compound developers, we offer custom lot testing—performing alongside their own teams to confirm performance. Rerunning reactions, reporting impurity levels, and validating consistency builds relationships that go far deeper than transactional sales.
Every kilogram produced teaches another lesson—how a pump slip, a mis-measured reagent, or a new purification tactic influences the final product. Our plant culture encourages learning and adaptability by tracking failures as closely as successes. This internal transparency rooted in daily briefings, debriefs, and archived run notes stops issues from repeating and helps onboard new members quickly and confidently.
Across years of manufacturing Methyl 4-Iodobenzoate, we’ve learned that trust, not trends, drives lasting demand. Feedback from academic and industrial partners shapes investments in better process control, upgraded analytical equipment, and, above all, clear communication. Product quality stands on concrete experience, old-fashioned human judgment, and the willingness to course-correct after unexpected results.
A single lot can represent weeks of careful work and dozens of hands. Pride grows from seeing a product leave the plant with every analytical test logged, every parameter met, and every safety measure observed. Communication—whether that means answering a troubleshooting call at midnight or sending early samples for validation—supports relationships that endure, through both smooth runs and the occasional hiccup. Our partners and their discoveries are as much part of our story as the chemistry itself.
We see every order for Methyl 4-Iodobenzoate as more than just a transaction. It’s an ongoing conversation between people who care about detail, performance, and mutual success. The expectation for tighter impurity profiles, more comprehensive documentation, or faster turnaround times challenges us to keep learning. As synthetic challenges grow more complex, so does our commitment to supporting the next wave of breakthroughs in chemistry, with the deep knowledge, pride, and precision honed by generations of plant workers.